We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.

Delisted

MBII was delisted on the 12th of July, 2022.

44 hedge funds and large institutions have $41.6M invested in Marrone Bio Innovations, Inc. in 2018 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 5

350% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 2

83% more funds holding

Funds holding: 2444 (+20)

39% less capital invested

Capital invested by funds: $68.1M → $41.6M (-$26.6M)

Holders
44
Holders Change
+20
Holders Change %
+83.33%
% of All Funds
1.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
25
Increased
9
Reduced
2
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AAP
1
Ardsley Advisory Partners
Connecticut
$13.4M
WRF
2
Waddell & Reed Financial
Kansas
$8.57M -$37.2M -20,000,000 -81%
BlackRock
3
BlackRock
New York
$4.96M +$4.87M +2,616,245 +3,363%
Primecap Management
4
Primecap Management
California
$4.83M
Vanguard Group
5
Vanguard Group
Pennsylvania
$4.14M +$2.25M +1,206,357 +115%
State Street
6
State Street
Massachusetts
$1.49M +$1.48M +797,071 +7,380%
Northern Trust
7
Northern Trust
Illinois
$943K +$894K +480,296 +1,504%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$607K +$448K +240,518 +269%
IAM
9
ICM Asset Management
Washington
$460K +$465K +250,000 New
Morgan Stanley
10
Morgan Stanley
New York
$215K +$217K +116,427 +24,256%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$214K +$216K +116,053 New
Deutsche Bank
12
Deutsche Bank
Germany
$192K +$195K +104,607 New
Charles Schwab
13
Charles Schwab
California
$188K +$189K +101,700 New
SIM
14
Spark Investment Management
New York
$165K +$168K +90,100 New
California State Teachers Retirement System (CalSTRS)
15
California State Teachers Retirement System (CalSTRS)
California
$154K +$155K +83,489 New
TCIM
16
TIAA CREF Investment Management
New York
$154K +$156K +83,774 New
Wells Fargo
17
Wells Fargo
California
$142K +$145K +77,711 New
TA
18
Teachers Advisors
New York
$138K +$140K +75,039 New
RhumbLine Advisers
19
RhumbLine Advisers
Massachusetts
$87K +$87.7K +47,127 New
Invesco
20
Invesco
Georgia
$65K +$65.4K +35,148 New
AIG
21
American International Group
New York
$65K +$66.2K +35,540 New
State Board of Administration of Florida Retirement System
22
State Board of Administration of Florida Retirement System
Florida
$50K +$50.8K +27,290 New
New York State Common Retirement Fund
23
New York State Common Retirement Fund
New York
$39K +$39.3K +21,100 New
Goldman Sachs
24
Goldman Sachs
New York
$38K +$38.4K +20,637 New
WIC
25
Whitegate Investment Counselors
New Hampshire
$28K

MBII Hedge Fund Activity: Q2 2018 in Review

44 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q2 2018, worth a combined $41.6M — down 39% from $68.1M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new MBII positions and 5 closed out — a net gain of 20 holders — while 9 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock, adding an estimated $4.87M. The largest seller was Waddell & Reed Financial, cutting an estimated $37.2M.

  • 44 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q2 2018, up from 24 in Q1 2018.
  • Funds reported $41.6M of Marrone Bio Innovations, Inc. stock for Q2 2018, down 39% quarter-over-quarter.
  • 25 funds opened new Marrone Bio Innovations, Inc. positions in Q2 2018 and 5 closed out, a net change of +20 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q2 2018 was BlackRock, an estimated $4.87M added.
  • The largest Marrone Bio Innovations, Inc. seller in Q2 2018 was Waddell & Reed Financial, an estimated $37.2M sold.

Based on aggregated 13F filings for Q2 2018.